Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4784844
Max Phase: Preclinical
Molecular Formula: C21H15N3O4
Molecular Weight: 373.37
Molecule Type: Unknown
Associated Items:
ID: ALA4784844
Max Phase: Preclinical
Molecular Formula: C21H15N3O4
Molecular Weight: 373.37
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(NO)c1ccc(CN2C(=O)c3cccnc3C2=O)cc1-c1ccccc1
Standard InChI: InChI=1S/C21H15N3O4/c25-19(23-28)15-9-8-13(11-17(15)14-5-2-1-3-6-14)12-24-20(26)16-7-4-10-22-18(16)21(24)27/h1-11,28H,12H2,(H,23,25)
Standard InChI Key: KINRGHJMNNIEQN-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 373.37 | Molecular Weight (Monoisotopic): 373.1063 | AlogP: 2.66 | #Rotatable Bonds: 4 |
Polar Surface Area: 99.60 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 8.94 | CX Basic pKa: 1.66 | CX LogP: 2.30 | CX LogD: 2.29 |
Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.42 | Np Likeness Score: -0.96 |
1. Mak JYW,Wu KC,Gupta PK,Barbero S,McLaughlin MG,Lucke AJ,Tng J,Lim J,Loh Z,Sweet MJ,Reid RC,Liu L,Fairlie DP. (2021) HDAC7 Inhibition by Phenacetyl and Phenylbenzoyl Hydroxamates., 64 (4.0): [PMID:33570940] [10.1021/acs.jmedchem.0c01967] |
Source(1):